ArticleFrontiers in molecular medicine2024

Immune-checkpoint-inhibitor therapy directed against PD-L1 is tolerated in the heart without manifestation of cardiac inflammation in a preclinical reversible melanoma mouse model.

Caroline Schoenherr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.